Outcomes in CAH: Need for evidence-based estimates [2]

Hormone Research

Volumn 68, Issue 4, 2007, Pages 203-

  Grosse, Scott D ^a   Van Vliet, Guy ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD DEATH; CONGENITAL ADRENAL HYPERPLASIA; DATA BASE; EVIDENCE BASED MEDICINE; HUMAN; LETTER; NEWBORN SCREENING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SALT LOSING NEPHRITIS;

EID: 36649003113     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103365     Document Type: Letter

References (4)

1. Strnadova KA, Votava F, Lebl J, Muhl A, Item C, Bodamer OA, et al: Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria. Eur J Pediatr 2007;166:1-4.
2. Votava F, Torok D, Kovacs J, Moslinger D, Baumgartner-Parzer SM, Solyom J, et al: Estimation of the false-negative rate in new-born screening for congenital adrenal hyperplasia. Eur J Endocrinol 2005;152:869-874.
3. National Newborn Screening and Genetic Resource Center: National Newborn Screening Information System. Available at: http://www2.uthscsa.edu/nnsis/. Accessed April 6, 2007.
4. Migeon CJ, Donohoue PA: Adrenal disorders; in Kappy MS, Blizzard RM, Migeon CJ (eds): The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence, ed 4. Springfield, Thomas, 1994, pp 717-856.